676
Views
0
CrossRef citations to date
0
Altmetric
Editorial

A thank-you note from the Chief-Editor

References

  • Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ, and the WFSBP Task Force on Mental Disorders in Primary Care; WFSBP Task Force on Anxiety Disorders, OCD and PTSD. 2012. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract. 16:77–84.
  • Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ, and WFSBP Task force on Treatment Guidelines For Anxiety; Obsessive-Compulsive and Post-Traumatic Stress Disorders. 2008b. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision. World J Biol Psychiatry. 9:248–312.
  • Bandelow B, Zohar J, Kasper S, Möller HJ. 2008a. How to grade categories of evidence. World J Biol Psychiatry. 9:242–247.
  • Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, Möller HJ, and WFSBP Task Force on Unipolar Depressive Disorders. 2007. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry. 8:67–104.
  • Bauer M, Pfennig A, Severus E, Whybrow PC, Angst J, Möller H-J, and WFSBP Task Force on Unipolar Depressive Disorders. 2013. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry. 14:334–385.
  • Bauer M, Severus E, Möller HJ, Young AH, and the WFSBP Task Force on Unipolar Depressive Disorder. 2017. Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines. Int J Psychiatry in Clin Pract. 21:166–176.
  • Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ, and WFSBP Task Force on Treatment Guidelines for Unipolar Depressive Disorders. 2002. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of major depressive disorder. World J Biol Psychiatry. 3:5–43.
  • Bocchio-Chiavetto L, Bagnardi V, Zanardini R, Molteni R, Gabriela Nielsen M, Placentino A, Giovannini C, Rillosi L, Ventriglia M, Riva MA, Gennarelli M. 2010. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J Biol Psychiatry. 11:763–773.
  • Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Möller HJ, and WFSBP Task Force on Treatment Guidelines for Schizophrenia. 2005. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: acute treatment of schizophrenia. World J Biol Psychiatry. 6:132–191.
  • Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S, and WFSBP Task Force On Treatment Guidelines For Bipolar Disorders. 2010. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry. 11:81–109.
  • Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S and WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. 2009. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry. 10:85–116.
  • Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S, and WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. 2013. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: Update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 14:154–219.
  • Hasan A, Bandelow B, Yatham LN, Berk M, Falkai P, Möller HJ, Kasper S, and WFSBP Guideline Task Force Chairs. 2019. WFSBP guidelines on how to grade treatment evidence for clinical guideline development. World J Biol Psychiatry. 20:2–16.
  • Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Möller HJ, and WFSBP Task Force on Treatment Guidelines for Schizophrenia. 2012. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry. 13:318–378.
  • Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthøj B, Gattaz WF, Thibaut F, Möller HJ, and the WFSBP Task Force on Treatment Guidelines for Schizophrenia. 2017. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia - a short version for primary care. Int J Psychiatry Clin Pract. 21:82–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.